DR. TIMOTHY L GILLISON MD NPI 1710905906

NPI Information

  • NPI: 1710905906
  • Provider Name: DR. TIMOTHY L GILLISON, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 900 N. 1ST STREET
    SPRINGFIELD, IL
    ZIP 62702
  • Phone: (217) 528-7541

Map and Directions

Get Directions

NPI Details

DR. Timothy L Gillison, MD is a hematology and oncology internal medicine in Springfield, IL with 22 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Timothy L Gillison, MD NPI is 1710905906. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2003

The provider's business location address is:

900 N. 1ST STREET
SPRINGFIELD, IL
ZIP 62702-749
Phone: (217) 528-7541
Fax: (217) 527-2830

The NPI 1710905906 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Iron binding capacity (HCPCS:83550)

The enumeration date for this NPI number is 7/17/2006 and was last updated on 5/22/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology036125875ILLINOISYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.